
Shabani, Moshi Moshi
@shabanimoshimo1
Listen, Learn, Evolve, Share
ID: 1251782445529169922
19-04-2020 07:59:48
393 Tweet
257 Followers
183 Following






Prof. Reinout van Crevel from Radboudumc, our partner in the PROTID trial, wrapped up an insightful talk on 'TB - translating research to better care & control' during the clinical meeting at Mbeya Zonal Referral Hospital MZRH is our longstanding partner & collaborator on patient recruitment


#WorldTBDay is a day to raise awareness about TB & efforts made to #EndTB Our research studies aim to contribute to World Health Organization (WHO)'s 'End TB Strategy' that aim for countries to reduce TB incidence by 80%, TB deaths by 90% & to eliminate catastrophic costs for TB-affected households by 2030


On TB day, EYP is proud to work with NIMR Mbeya in different aspect to add up efforts to end TB. On the photo is one of our Volunteer at EYP health committee Dr Moshi Shabani .He is at NIMR Mbeya in Tb department working on medications that will shorten time for TB treatment.


Very proud that one of our outstanding interns, Dr. Moshi Shabani Shabani, Moshi Moshi clinched a prestigious grant, the Gilead Public health scholars award Gilead Sciences This is a testament to hardwork & exceptional mentorship fostered by our institution through internship program


FORUM: Ifakara at the Primary Health Care Conference 2024 From March 25-27, 2024, Ifakara Health Institute has been participating in the 1st International Primary Health Care Conference (#IPHCC2024) held at the Jakaya Kikwete Convention Centre in Dodoma, Tanzania. This conference,


We stand firm in our commitment to the global liver community as we work together to help achieve the World Health Organization (WHO)'s goal of eliminating viral hepatitis as a public health threat by 2030. We're sharing our latest research and knowledge at #APASL2024.


NEWS: Ifakara science director on promising new malaria vaccine On July 10, 2024, Dr. Ally Olotu, Director of Science at Ifakara Health Institute, shared exciting news with Azam TV about the new malaria vaccine "RH5.1/Matrix-M," showing great promise in early trials! π¦π Conducted



#IASC2024 Wrapping up on a high note! We celebrated excellence with awards recognizing outstanding contributions of our scientists in turbo talks, oral presentations, and poster presentations. ππ The Ifakara Health Institute CED, Dr. Honorati Masanja, closed the event with a call to
